tradingkey.logo

Fortrea Holdings Inc

FTRE
9.668USD
0.0000.00%
終値 11/03, 16:00ET15分遅れの株価
877.85M時価総額
損失額直近12ヶ月PER

Fortrea Holdings Inc

9.668
0.0000.00%

詳細情報 Fortrea Holdings Inc 企業名

Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.

Fortrea Holdings Incの企業情報

企業コードFTRE
会社名Fortrea Holdings Inc
上場日Jun 16, 2023
最高経営責任者「CEO」Mr. Anshul Thakrala
従業員数15500
証券種類Ordinary Share
決算期末Jun 16
本社所在地8 Moore Drive
都市DURHAM
証券取引所NASDAQ Global Select Consolidated
United States of America
郵便番号27709
電話番号18774950816
ウェブサイトhttps://www.fortrea.com/
企業コードFTRE
上場日Jun 16, 2023
最高経営責任者「CEO」Mr. Anshul Thakrala

Fortrea Holdings Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
98.13K
+175.40%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
13.64K
+114.60%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
13.64K
+114.60%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
9.54K
+114.62%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
7.28K
--
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Mark Morais
Mr. Mark Morais
Chief Operating Officer and President - Clinical Services
Chief Operating Officer and President - Clinical Services
--
--
Mr. William J. (Bill) Sharbaugh
Mr. William J. (Bill) Sharbaugh
Director
Director
--
--
Ms. Erin L. Russell
Ms. Erin L. Russell
Independent Director
Independent Director
--
--
Ms. Hima B. Inguva
Ms. Hima B. Inguva
Investor Relations
Investor Relations
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
98.13K
+175.40%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
13.64K
+114.60%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
13.64K
+114.60%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
9.54K
+114.62%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
7.28K
--
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2021
FY2020
データなし
地域別USD
会社名
収益
比率
North America
344.30M
48.47%
Europe
218.70M
30.79%
Other
147.30M
20.74%
事業別
地域別
データなし

株主

更新時刻: Sat, Aug 16
更新時刻: Sat, Aug 16
株主統計
種類
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
14.03%
The Vanguard Group, Inc.
9.37%
Goldman Sachs & Company, Inc.
8.53%
AQR Capital Management, LLC
7.18%
Corvex Management LP
4.97%
他の
55.93%
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
14.03%
The Vanguard Group, Inc.
9.37%
Goldman Sachs & Company, Inc.
8.53%
AQR Capital Management, LLC
7.18%
Corvex Management LP
4.97%
他の
55.93%
種類
株主統計
比率
Investment Advisor
45.71%
Hedge Fund
24.43%
Investment Advisor/Hedge Fund
22.87%
Research Firm
13.87%
Bank and Trust
2.55%
Pension Fund
2.34%
Individual Investor
0.52%
Family Office
0.39%
Sovereign Wealth Fund
0.05%

機関投資家保有株

更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
948
101.58M
111.87%
-11.06M
2025Q2
941
91.16M
100.39%
-22.39M
2025Q1
942
95.79M
105.84%
-17.15M
2024Q4
898
97.88M
109.12%
-17.67M
2024Q3
853
101.51M
113.29%
-12.93M
2024Q2
825
103.91M
116.10%
+693.93K
2024Q1
782
93.40M
104.47%
-524.01K
2023Q4
716
91.67M
103.23%
-7.08M
2023Q3
616
90.69M
102.13%
+51.44M
2023Q2
43
6.20M
7.00%
+6.20M

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
BlackRock Institutional Trust Company, N.A.
12.74M
14.03%
+1.79M
+16.37%
Jun 30, 2025
The Vanguard Group, Inc.
8.51M
9.37%
-1.34M
-13.61%
Jun 30, 2025
Goldman Sachs & Company, Inc.
7.74M
8.53%
+7.70M
+19444.90%
Jun 30, 2025
AQR Capital Management, LLC
6.52M
7.18%
+5.42M
+494.84%
Jun 30, 2025
Corvex Management LP
4.51M
4.97%
+33.63K
+0.75%
Jun 30, 2025
State Street Investment Management (US)
4.43M
4.88%
+1.17M
+35.82%
Jun 30, 2025
Sessa Capital
3.99M
4.4%
-700.00K
-14.91%
Jun 30, 2025
Fidelity Management & Research Company LLC
2.98M
3.28%
-1.07M
-26.50%
Jun 30, 2025
Starboard Value LP
2.50M
2.75%
-220.86K
-8.13%
Jun 30, 2025
Geode Capital Management, L.L.C.
2.17M
2.39%
+589.14K
+37.23%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Sun, Nov 2
更新時刻: Sun, Nov 2
銘柄名
比率
Brandes US Small-Mid Cap Value ETF
1.13%
Invesco S&P Spin-Off ETF
0.83%
Invesco S&P SmallCap Health Care ETF
0.49%
Invesco S&P SmallCap 600 Pure Value ETF
0.19%
Invesco S&P SmallCap 600 Revenue ETF
0.17%
Schwab Fundamental U.S. Small Company ETF
0.14%
Humankind US Stock ETF
0.12%
SPDR S&P 600 Small Cap Value ETF
0.11%
iShares S&P Small-Cap 600 Value ETF
0.11%
ProShares Ultra Nasdaq Biotechnology
0.08%
詳細を見る
Brandes US Small-Mid Cap Value ETF
比率1.13%
Invesco S&P Spin-Off ETF
比率0.83%
Invesco S&P SmallCap Health Care ETF
比率0.49%
Invesco S&P SmallCap 600 Pure Value ETF
比率0.19%
Invesco S&P SmallCap 600 Revenue ETF
比率0.17%
Schwab Fundamental U.S. Small Company ETF
比率0.14%
Humankind US Stock ETF
比率0.12%
SPDR S&P 600 Small Cap Value ETF
比率0.11%
iShares S&P Small-Cap 600 Value ETF
比率0.11%
ProShares Ultra Nasdaq Biotechnology
比率0.08%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし
KeyAI